Your browser doesn't support javascript.
loading
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy.
Bond, David A; Switchenko, Jeffrey M; Villa, Diego; Maddocks, Kami; Churnetski, Michael; Gerrie, Alina S; Goyal, Subir; Shanmugasundaram, Krithika; Calzada, Oscar; Kolla, Bhaskar; Bachanova, Veronika; Gerson, James N; Barta, Stefan K; Hill, Brian T; Sawalha, Yazeed; Martin, Peter; Maldonado, Edward; Gordon, Max; Danilov, Alexey V; Grover, Natalie S; Mathews, Stephanie; Burkart, Madelyn; Karmali, Reem; Ghosh, Nilanjan; Park, Steven I; Epperla, Narendranath; Badar, Talha; Guo, Jin; Hamadani, Mehdi; Fenske, Timothy S; Malecek, Mary-Kate; Kahl, Brad S; Flowers, Christopher R; Blum, Kristie A; Cohen, Jonathon B.
Afiliação
  • Bond DA; Division of Hematology, The Ohio State University, Columbus, OH.
  • Switchenko JM; Winship Cancer Institute, Biostatistics and Bioinformatics, Emory University, Atlanta, GA.
  • Villa D; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Maddocks K; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada.
  • Churnetski M; Division of Hematology, The Ohio State University, Columbus, OH.
  • Gerrie AS; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Goyal S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Shanmugasundaram K; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada.
  • Calzada O; Winship Cancer Institute, Biostatistics and Bioinformatics, Emory University, Atlanta, GA.
  • Kolla B; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Bachanova V; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Gerson JN; Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN.
  • Barta SK; Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN.
  • Hill BT; Division of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.
  • Sawalha Y; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Martin P; Division of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.
  • Maldonado E; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Gordon M; Department of Hematology and Medical Oncology, Taussig Cancer Institute,Cleveland Clinic, Cleveland, OH.
  • Danilov AV; Division of Hematology, The Ohio State University, Columbus, OH.
  • Grover NS; Department of Hematology and Medical Oncology, Taussig Cancer Institute,Cleveland Clinic, Cleveland, OH.
  • Mathews S; Division of Hematology and Oncology, Weill Cornell Medical Center/New York Presbyterian Hospital, New York, NY.
  • Burkart M; Knight Cancer Institute, Oregon Health Sciences University, Portland, OR.
  • Karmali R; Knight Cancer Institute, Oregon Health Sciences University, Portland, OR.
  • Ghosh N; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX.
  • Park SI; Knight Cancer Institute, Oregon Health Sciences University, Portland, OR.
  • Epperla N; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA.
  • Badar T; Division of Hematology, University of North Carolina, Chapel Hill, NC.
  • Guo J; Division of Hematology, University of North Carolina, Chapel Hill, NC.
  • Hamadani M; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Division of Hematology, Northwestern University, Chicago, IL.
  • Fenske TS; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Division of Hematology, Northwestern University, Chicago, IL.
  • Malecek MK; Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Kahl BS; Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Flowers CR; Division of Hematology, The Ohio State University, Columbus, OH.
  • Blum KA; BMT Cellular Therapy Program, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI; and.
  • Cohen JB; Division of Hematology and Oncology, Weill Cornell Medical Center/New York Presbyterian Hospital, New York, NY.
Blood Adv ; 5(23): 5179-5189, 2021 12 14.
Article em En | MEDLINE | ID: mdl-34516611
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article